Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹459.20Admitted-Finance H NO 01 EXTN 01 SUBASH NAGAR JAMMU J K 180007 | JAMMU | JAMMU | JAMMU AND KASHMIR | 180007 | ₹459.20 | L1 | Admitted-Finance |
| 2 | L2₹8,251.45+₹7,792.25 (1696.9%)Admitted-Finance B 175 EAST OF KAILASH NEW DELHI DELHI 110065 | SOUTH EAST DELHI | DELHI | 110065 | ₹8,251.45+₹7,792.25 (1696.9%) | L2 | Admitted-Finance |
| 3 | L3₹11,467.23+₹11,008.03 (2397.2%)Admitted-Finance | ₹11,467.23+₹11,008.03 (2397.2%) | L3 | Admitted-Finance |
| 4 | L4₹28,939.31+₹28,480.11 (6202.1%)Admitted-Finance | ₹28,939.31+₹28,480.11 (6202.1%) | L4 | Admitted-Finance |
| 5 | L5₹5.0 L+₹5.0 L (108214.6%)Admitted-Finance | ₹5.0 L+₹5.0 L (108214.6%) | L5 | Admitted-Finance |
| Sl No | Description | Qty | Unit | Medikon India L5 | MEHTA ENTERPRISES L1 | IMPEX INDIA L3 | HM Life Sciences L4 | ALBINO LIFESCIENCES PVT LTD L2 |
|---|---|---|---|---|---|---|---|---|
| 1.00Dept of Oncology | ||||||||
| 1.01 | Tab Lenvatinib 10 mg | 630 | No | - | 285 ₹319.2 | 225.9 ₹253.01 Lowest | 2,249.29 ₹2,519.2 | 282.5 ₹316.4 |
| 2.01 | Tab Lenvatinib 4 mg | 270 | No | - | 125 ₹140 | 112.7 ₹126.22 Lowest | 899.71 ₹1,007.68 | 119.86 ₹134.24 |
| 3.01 | Eribulin Mesylate 1 mg | 132 | Vial | - | - | 9,900 ₹11,088 | 22,142.86 ₹24,800 | 6,965 ₹7,800.8 Lowest |
| 4.01 | Inj Pertuzumab 420 mg | 39 | Vial | 1,69,330 ₹1,89,649.6 Lowest | - | - | - | - |
| 5.01 | Inj Trastuzumab-emtansine 100 mg | 27 | Vial | 1,05,680 ₹1,18,361.6 Lowest | - | - | - | - |
| 6.01 | Inj Trastuzumab-emtansine 160 mg | 27 | Vial | 1,69,080 ₹1,89,369.6 Lowest | - | - | - | - |
| 7.01 | Cap Ceritinib 150 mg | 1,485 | No | - | - | - | 546.81 ₹612.43 Lowest | - |
Tender Value
₹1.9 Cr
EMD Value
₹9.7 L
Closing Date
23 Nov 2020, 1:00 pmClosed
COMMANDANT ARMY HOSPITAL R AND R DELHI CANTT-10
COMMANDANT ARMY HOSPITAL R AND R DELHI CANTT-10
2337-2433/MS/Exp/D-12/Oncology(Drugs)/RE-90/2020-21 Dt 03 Nov 2020 For AHRR
2020_ARMY_392069_2
2337-2433/D-12/ Onco /RE-90/Nov-20
Open Tender
Medical Equipments/Waste
Buy
30 days
ARMY HOSPITAL R AND R DELHI CANTT-10
Please refer Tender documents.
2 documents required · 2 mandatory
₹0
₹9.7 L
Yes
31 Dec 2020
3 Nov 2020
24 Nov 2020
3 Nov 2020
23 Nov 2020
3 Nov 2020
3 Nov 2020 - 23 Nov 2020
Dept of Oncology
Tab Lenvatinib 10 mg
Tab Lenvatinib 4 mg
Eribulin Mesylate 1 mg
Inj Pertuzumab 420 mg
Inj Trastuzumab-emtansine 100 mg
Inj Trastuzumab-emtansine 160 mg
Cap Ceritinib 150 mg
ALBINO LIFESCIENCES PVT LTD
IMPEX INDIA
HM Life Sciences
Medikon India
IMPEX INDIA
HM Life Sciences
ALBINO LIFESCIENCES PVT LTD
stage.html
html • 0.03 MB
tech_bid_open.pdf
tech_eval.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.11 MB
RFP.pdf
Tender Documents • 0.40 MB
BOQ_437519.xls
BOQ • 0.28 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .